Literature DB >> 27081551

Exome sequencing identifies novel mutations in C5orf42 in patients with Joubert syndrome with oral-facial-digital anomalies.

Ingrid M Wentzensen1, Jennifer J Johnston2, Kim Keppler-Noreuil2, Karina Acrich3, Karen David3, Kisha D Johnson4, John M Graham5, Julie C Sapp2, Leslie G Biesecker2.   

Abstract

Oral-facial-digital syndrome VI (OFD6 OMIM #277170), also called Varadi-Papp syndrome, is a ciliopathy inherited in an autosomal recessive pattern. Recently, mutations in C5orf42 (OMIM #614571) have been associated with OFD6. OFD6 overlaps with Joubert syndrome and mutations in C5orf42 were described in Joubert syndrome 17 (JBTS17, OMIM #614571). Using exome sequencing we report three novel variants and one previously reported variant in the C5orf42 gene in patients with OFD6.

Entities:  

Year:  2015        PMID: 27081551      PMCID: PMC4785546          DOI: 10.1038/hgv.2015.45

Source DB:  PubMed          Journal:  Hum Genome Var        ISSN: 2054-345X


Joubert syndrome (JBTS) comprises hypotonia, apnea or hyperpnea in infancy, oculomotor apraxia and variable intellectual impairment.[1] The key feature is a complex brain malformation comprising small or absent cerebellar vermis, deepened interpeduncular fossa and elongated superior cerebellar peduncles called the molar tooth sign. Involvement of liver (i.e., congenital liver fibrosis), kidneys (i.e., polycystic kidneys), eyes (i.e., retinopathy), polydactyly or oral–facial abnormalities led to the subclassification of Joubert syndrome and related disorders.[2] Oral–facial–digital syndrome VI (OFD6) overlaps with JBTS with respect to key features and also has tongue hamartomas and/or frenulae, upper lip notch, mesoaxial polydactyly of hands or feet, and hypothalamic hamartoma. It has been categorized as Joubert syndrome with oro-facio-digital defects (JS-OFD or JBTS17, OMIM #614615). Family 1: Two fetuses conceived by a consanguineous (first cousin union) couple from Saudi Arabia. Both were terminated owing to multiple anomalies including post- and preaxial polydactyly on hands with cutaneous syndactyly of hands and feet. On physical examination low-set ears were present, as well as clubfeet. The first fetus also had cleft palate; the second one had anal atresia. Autopsy showed absent cerebellar vermis, a small cerebellum, abnormal gyration, dysplastic corpus callosum and small, cystic kidneys. The second fetus had a single-nucleotide polymorphism microarray showing large areas of homozygosity, but no significant copy-number variation. Family 2: The proband in family 2 is a 15-year-old female, who had tongue hamartomata, mesoaxial polydactyly, mild preaxial polydactyly of feet (bifid great toes) and small cerebellar vermis (Figure 1). Other clinical features included bifid epiglottis, esotropia and nystagmus. She had apparent cognitive impairment, unsteady gait and difficulties with articulation. Family history is significant for an older sister who died following surgery for a congenital heart defect associated with a mosaic 45,X/46,XX karyotype. This sister also had preaxial polydactyly of feet (bifid great toes) and absence of the posterior cerebellar vermis, strongly suggesting she was also affected with OFD6.
Figure 1

Fifteen-year old proband of Family 2. (a) Mesoaxial polydactyly hands. (b) Mild preaxial polydactyly feet (bifid great toes). (c) Small cerebellar vermis.

Previous genetic testing included a microarray that showed a 3-MB deletion on the X chromosome (chrX:88,362,258–92,257,523). This deletion includes 15 genes, 3 of which are currently described in OMIM, none are associated with a clinical phenotype to date. None of these were a good candidate for the patient's findings. Sanger sequencing for GLI3 (OMIM #165240) was negative (data not shown). Family 3: The proband in family 3 was a 1-day-old male infant delivered to a 30-year-old G2P2 Mexican mother. On prenatal ultrasound, the fetus was found to have a large posterior encephalocele, cleft lip and palate and bilateral preaxial polydactyly of the feet. Amniocentesis chromosome analysis was normal and microarray revealed a 169.7-kb loss on 6p21.33 of no known clinical significance. Birth weight was 3,565 grams (50th centile). He expired on the first day of life. On physical examination he had a large posterior encephalocele, cleft lip and palate, micropenis, bilateral undescended testes, postaxial polydactyly of both hands and seven toes bilaterally (with preaxial and postaxial polydactyly) and cutaneous syndactyly of the first and second toes. Autopsy showed occipital encephalocele containing partial herniation of the cerebellum, diffuse polymicrogyria, multifocal heterotopia, absent cerebellar vermis, fused thalami, arrhinencephaly, ventriculomegaly and hypothalamic hamartoma. Family history was significant for consanguinity (first cousin union) and a similarly affected male sibling who died at 5 months of age. Findings in the sibling included macrocephaly, communicating hydrocephalus, Dandy–Walker malformation and absence of cerebellar vermis. Additional features were widely spaced eyes with downslanted palpebral fissures, anteverted nares, soft palate cleft, excess nuchal skin, postaxial polydactyly of hands and bilateral preaxial and postaxial polydactyly of feet. Exome sequencing on the probands and parents (only the mother in the second family) was performed as part of an effort to expand the mutational spectrum of patients with overlapping features of known GLI3-related phenotypes and oral–facial–digital syndromes with the common attribute of polydactyly. DNA was isolated from whole blood using the salting out method (Qiagen, Germantown, MD, USA) following the manufacturer’s instructions. Exome sequencing was performed as described.[3] Filters were implemented using VarSifter software program (Bethesda, MD, USA) for exome and genome sequencing data management.[4] Variants were filtered for predicted loss of function and for absence from 938 controls. Sanger sequence analyses of all mutations were performed as described.[5] Sequence data were compared with the published C5orf42 sequence (GenBank reference NM_023073.3) using Sequencher 5.0.1 (Gene Codes, Ann Arbor, MI, USA). This study was reviewed and approved by the NHGRI Institutional Review Board. Informed consent was obtained from all families. Exome sequencing in Family 1 showed a homozygous variant in C5orf42, c.8471-1G>C. This novel splice-site mutation was not present in the Human Gene Mutation Database (HGMD, Version 2014.2) or in the Exome Variant Server, NHLBI GO Exome Sequencing Project (ESP, Version ESP6500SI-V2, Seattle, WA, USA; http://evs.gs.washington.edu/EVS). In addition, it was not present in 938 internal control individuals (ClinSeq data set, NHGRI, Bethesda, MD, USA). Both parents were heterozygous carriers. DNA was unavailable on the affected sibling. In Family 2 compound heterozygous variants were identified in C5orf42, c.3599C>T, p.Ala1200Val and c.2920+1G>A. The c.3599C>T variant was previously described.[6] The c.2920+1G>A variant was novel. Neither variant was present in the ESP dataset or 938 ClinSeq individuals. This patient shares this mutation with her mother. DNA of the father was unavailable. We attempted to amplify a sample of the deceased sister, but DNA appeared to be degraded (data not shown). We hypothesize that her sister had OFD6 owing to her findings in addition to mosaic Turner syndrome. In Family 3 exome sequencing identified a novel homozygous variant, c.7662_7666del, p.Ser2555Argfs*11. This variant was not present in HGMD, the ESP dataset or 938 ClinSeq individuals. The affected sibling was also homozygous for this mutation and both parents were heterozygous. C5orf42 was recently identified as the causative gene for this malformation syndrome. Little is known about the function of C5orf42 within the ciliopathy protein network. Exome sequencing in 15 individuals from 11 families with JBTS in Quebec identified 6 distinct mutations in 9 patients of 7 families.[7] All patients had cognitive impairment. The majority of patients had oculomotor apraxia and breathing abnormalities; two patients had pre- and postaxial polydactyly and cutaneous syndactyly. Another report described 12 consanguineous Saudi Arabian families with Joubert syndrome.[8] In three families, mutations in C5orf42 were identified. Occipital meningocele was present in one patient. Last, Lopez et al. identified 14 homozygous or compound heterozygous mutations in the C5orf42 gene in 12 patients in 9 of 11 families with OFD6. Of note, typical features of ciliopathies, such as polycystic kidney disease and retinal disease were not present.[9] The authors concluded that while some patients in their cohort had mutations in TMEM216, C5orf42 was the most commonly mutated gene. In contrast, Romani et al. recently sequenced C5orf42 in 313 patients with JBTS. They identified mutations in 28 (8.9%) of their probands with pure Joubert syndrome. Only 2 out of 17 (11.7%) with features of OFD6 harbored a pathogenic variant in C5orf42. A comparison of mutated versus non-mutated OFD6 patients showed that preaxial and mesoaxial polydacytyly, hypothalamic hamartoma and other congenital defects may predict C5orf42 mutations, whereas tongue hamartomas appear to be more common in patients without an identified mutation.[10] All of the probands described in our report had pre- post- or mesoaxial polydactyly which is concordant. The 15-year-old female we describe, however, did have tongue hamartomas in contrast to their conclusion. No clear genotype–phenotype relations have been elucidated. The local clustering in French Canada led to the hypothesis of a founder effect, but the findings of several different mutations did not support this. With the publication of more patients, it has thus been shown that C5orf42 is likely a common gene in patients with Joubert syndrome with oral–facial findings.[9] Our findings with three additional novel mutations support this hypothesis. One of the patients described had anal atresia. To the best of our knowledge, this finding has not yet been associated with the phenotype. This patient was the offspring of a first-cousin union supported by large areas of homozygosity on microarray. It could be a novel finding, but we suspect it is likely unrelated and an additional finding in this consanguineous family. In summary, we report three novel mutations in the C5orf42 gene in patients with OFD6. Our findings support recent results that C5orf42 is the major gene mutated in patients with OFD6. Mutations are associated with a wide clinical spectrum comprising overlapping features of JBTS and oral–facial–digital syndromes as well as with Pallister–Hall and Greig Cephalopolysyndactyly syndromes. The use of next-generation sequencing is slowly, but significantly expanding the phenotypic spectrum of disorders as less typically affected patients are analyzed. This is referred to as phenotypic expansion. This improved understanding of genotype–phenotype relationships facilitates diagnosis, refines our ability to predict phenotype from genotype, and provides insights into the biology of normal and abnormal development.
  10 in total

1.  VarSifter: visualizing and analyzing exome-scale sequence variation data on a desktop computer.

Authors:  Jamie K Teer; Eric D Green; James C Mullikin; Leslie G Biesecker
Journal:  Bioinformatics       Date:  2011-12-30       Impact factor: 6.937

2.  Mutations in C5ORF42 cause Joubert syndrome in the French Canadian population.

Authors:  Myriam Srour; Jeremy Schwartzentruber; Fadi F Hamdan; Luis H Ospina; Lysanne Patry; Damian Labuda; Christine Massicotte; Sylvia Dobrzeniecka; José-Mario Capo-Chichi; Simon Papillon-Cavanagh; Mark E Samuels; Kym M Boycott; Michael I Shevell; Rachel Laframboise; Valérie Désilets; Bruno Maranda; Guy A Rouleau; Jacek Majewski; Jacques L Michaud
Journal:  Am J Hum Genet       Date:  2012-03-15       Impact factor: 11.025

3.  Molecular characterization of Joubert syndrome in Saudi Arabia.

Authors:  Anas M Alazami; Muneera J Alshammari; Mustafa A Salih; Fatema Alzahrani; Hadia Hijazi; Mohammed Z Seidahmed; Leen Abu Safieh; Mazhor Aldosary; Arif O Khan; Fowzan S Alkuraya
Journal:  Hum Mutat       Date:  2012-07-11       Impact factor: 4.878

Review 4.  Joubert Syndrome and related disorders.

Authors:  Francesco Brancati; Bruno Dallapiccola; Enza Maria Valente
Journal:  Orphanet J Rare Dis       Date:  2010-07-08       Impact factor: 4.123

5.  Long-term survival in TARP syndrome and confirmation of RBM10 as the disease-causing gene.

Authors:  Karen W Gripp; Elizabeth Hopkins; Jennifer J Johnston; Caitlin Krause; William B Dobyns; Leslie G Biesecker
Journal:  Am J Med Genet A       Date:  2011-09-09       Impact factor: 2.802

6.  Expansion of the TARP syndrome phenotype associated with de novo mutations and mosaicism.

Authors:  Jennifer J Johnston; Julie C Sapp; Cynthia Curry; Margaret Horton; Eyby Leon; Kristina Cusmano-Ozog; William B Dobyns; Louanne Hudgins; Elaine Zackai; Leslie G Biesecker
Journal:  Am J Med Genet A       Date:  2013-11-20       Impact factor: 2.802

Review 7.  The ciliopathies in neuronal development: a clinical approach to investigation of Joubert syndrome and Joubert syndrome-related disorders.

Authors:  Shifteh Sattar; Joseph G Gleeson
Journal:  Dev Med Child Neurol       Date:  2011-06-17       Impact factor: 5.449

8.  Diagnostic utility of whole exome sequencing in patients showing cerebellar and/or vermis atrophy in childhood.

Authors:  Chihiro Ohba; Hitoshi Osaka; Mizue Iai; Sumimasa Yamashita; Yume Suzuki; Noriko Aida; Nobuyuki Shimozawa; Ayumi Takamura; Hiroshi Doi; Atsuko Tomita-Katsumoto; Kiyomi Nishiyama; Yoshinori Tsurusaki; Mitsuko Nakashima; Noriko Miyake; Yoshikatsu Eto; Fumiaki Tanaka; Naomichi Matsumoto; Hirotomo Saitsu
Journal:  Neurogenetics       Date:  2013-10-04       Impact factor: 2.660

9.  C5orf42 is the major gene responsible for OFD syndrome type VI.

Authors:  Estelle Lopez; Christel Thauvin-Robinet; Bruno Reversade; Nadia El Khartoufi; Louise Devisme; Muriel Holder; Hélène Ansart-Franquet; Magali Avila; Didier Lacombe; Pascale Kleinfinger; Irahara Kaori; Jun-Ichi Takanashi; Martine Le Merrer; Jelena Martinovic; Catherine Noël; Mohammad Shboul; Lena Ho; Yeliz Güven; Ferechté Razavi; Lydie Burglen; Nadège Gigot; Véronique Darmency-Stamboul; Julien Thevenon; Bernard Aral; Hülya Kayserili; Frédéric Huet; Stanislas Lyonnet; Cédric Le Caignec; Brunella Franco; Jean-Baptiste Rivière; Laurence Faivre; Tania Attié-Bitach
Journal:  Hum Genet       Date:  2013-11-01       Impact factor: 4.132

10.  Oral-facial-digital syndrome type VI: is C5orf42 really the major gene?

Authors:  Marta Romani; Francesca Mancini; Alessia Micalizzi; Andrea Poretti; Elide Miccinilli; Patrizia Accorsi; Emanuela Avola; Enrico Bertini; Renato Borgatti; Romina Romaniello; Serdar Ceylaner; Giangennaro Coppola; Stefano D'Arrigo; Lucio Giordano; Andreas R Janecke; Mario Lituania; Kathrin Ludwig; Loreto Martorell; Tommaso Mazza; Sylvie Odent; Lorenzo Pinelli; Pilar Poo; Margherita Santucci; Sabrina Signorini; Alessandro Simonati; Ronen Spiegel; Franco Stanzial; Maja Steinlin; Brahim Tabarki; Nicole I Wolf; Federica Zibordi; Eugen Boltshauser; Enza Maria Valente
Journal:  Hum Genet       Date:  2014-11-19       Impact factor: 4.132

  10 in total
  8 in total

1.  Disabling Myoclonus in a Case of Joubert Syndrome.

Authors:  Vikram Venkappayya Holla; Albert Stezin; Sudhakar Pushpa Chaithra; Nitish Kamble; Ravi Yadav; Pramod Kumar Pal
Journal:  Mov Disord Clin Pract       Date:  2020-04-06

2.  Targeted Next-Generation Sequencing Identifies Pathogenic Variants in Diabetic Kidney Disease.

Authors:  Jose Lazaro-Guevara; Julio Fierro-Morales; A Hunter Wright; River Gunville; Christopher Simeone; Scott G Frodsham; Melissa H Pezzolesi; Courtney A Zaffino; Laith Al-Rabadi; Nirupama Ramkumar; Marcus G Pezzolesi
Journal:  Am J Nephrol       Date:  2021-03-26       Impact factor: 3.754

3.  Clinical heterogeneity and intrafamilial variability of Joubert syndrome in two siblings with CPLANE1 variants.

Authors:  Xiujuan Zhang; Yue Shen; Ping Li; Ruikun Cai; Chao Lu; Qian Li; Cuixia Chen; Yufei Yu; Tingting Cheng; Xian Wang; Minna Luo; Muqing Cao; Zongfu Cao; Xu Ma
Journal:  Mol Genet Genomic Med       Date:  2021-04-06       Impact factor: 2.183

4.  Clinical and experimental evidence suggest a link between KIF7 and C5orf42-related ciliopathies through Sonic Hedgehog signaling.

Authors:  Reza Asadollahi; Justin E Strauss; Martin Zenker; Oliver Beuing; Simon Edvardson; Orly Elpeleg; Tim M Strom; Pascal Joset; Dunja Niedrist; Christine Otte; Beatrice Oneda; Paranchai Boonsawat; Silvia Azzarello-Burri; Deborah Bartholdi; Michael Papik; Markus Zweier; Cordula Haas; Arif B Ekici; Alessandra Baumer; Eugen Boltshauser; Katharina Steindl; Michael Nothnagel; Albert Schinzel; Esther T Stoeckli; Anita Rauch
Journal:  Eur J Hum Genet       Date:  2018-01-10       Impact factor: 4.246

5.  Ciliopathies: Coloring outside of the lines.

Authors:  Alanna Strong; Dong Li; Frank Mentch; Emma Bedoukian; Erum A Hartung; Kevin Meyers; Cara Skraban; Jessica Wen; Livija Medne; Joseph Glessner; Deborah Watson; Ian Krantz; Hakon Hakonarson
Journal:  Am J Med Genet A       Date:  2020-12-25       Impact factor: 2.802

Review 6.  Genotype-phenotype correlates in Joubert syndrome: A review.

Authors:  Simone Gana; Valentina Serpieri; Enza Maria Valente
Journal:  Am J Med Genet C Semin Med Genet       Date:  2022-03-03       Impact factor: 3.359

7.  Prenatal Diagnosis and Genetic Analysis of a Fetus with Joubert Syndrome.

Authors:  Jingjing Xiang; Lili Zhang; Wei Jiang; Qin Zhang; Ting Wang; Haibo Li; Hong Li
Journal:  Biomed Res Int       Date:  2018-05-31       Impact factor: 3.411

8.  Expanding the genetic landscape of oral-facial-digital syndrome with two novel genes.

Authors:  Alanna Strong; Laurie Simone; Anthony Krentz; Courtney Vaccaro; Deborah Watson; Hayley Ron; Jennifer M Kalish; Helio F Pedro; Elaine H Zackai; Hakon Hakonarson
Journal:  Am J Med Genet A       Date:  2021-06-15       Impact factor: 2.802

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.